Immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma delta T cell engagers to treat cancer.

ID: 1318269638468378625

linkhttp://www.lavatherapeutics.com calendar_today19-10-2020 19:15:58